Related Experiment Video
Updated: Aug 23, 2026

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
Risk of combined coronary artery bypass and mitral valve replacement
S S Kabbani1, T T Bashour, E S Hanna
1Western Heart Institute, St. Mary's Hospital and Medical Center, and the University of California, San Francisco, California 94117, USA.
Insights
Combined coronary artery bypass and mitral valve replacement carries high risks, especially for patients with extensive coronary artery disease and left ventricular dysfunction. Caution is advised due to factors like ischemia and advanced heart failure impacting outcomes.
Area of Science:
- Cardiology
- Cardiac Surgery
- Cardiovascular Medicine
Background:
- Combined coronary artery bypass (CAB) and mitral valve replacement (MVR) is a complex procedure.
- Assessing risk factors for combined CAB and MVR is crucial for patient outcomes.
Purpose of the Study:
- To evaluate operative mortality and identify risk factors in patients undergoing combined CAB and MVR.
- To compare outcomes among patient subgroups based on preoperative variables.
Main Methods:
- Retrospective analysis of 42 patients (26 men, 16 women, aged 53-80) undergoing combined CAB and MVR.
- Preoperative cardiac catheterization to assess hemodynamic and surgical variables.
- Evaluation of operative mortality and comparison across subgroups.
Main Results:
- Eight patients (19%) died during the study period.
- Adverse factors influencing mortality included ischemic instability, advanced New York Heart Association class, severe mitral/aortic regurgitation, extensive coronary artery disease, left ventricular dysfunction (elevated LVEDP, low EF), and high pulmonary vascular resistance.
- Prolonged operative time was also a significant risk factor.
- Mitral valve pathology type did not influence mortality.
Conclusions:
- Combined CAB and MVR is associated with high risk, particularly in patients with extensive coronary artery disease and advanced left ventricular dysfunction.
- Caution is recommended when considering this combined procedure for high-risk patients.
- Further evaluation of pre- and postoperative afterload reduction and circulatory assist devices may be beneficial.
Abstract:
During a period of 6 years and 5 months, a group of 26 men and 16 women between 53 and 80 years of age underwent combined coronary artery bypass and mitral valve replacement. All patients were catheterized preoperatively, and hemodynamic and surgical variables were noted. In accordance with the variables, operative mortality was evaluated and compared among subgroups. Eight patients died, and the factors found to adversely change successful treatment were instability of ischemia, advanced New York Heart Association functional class, severe mitral regurgitation, associated aortic regurgitation, extensive coronary artery disease, the extent of left ventricular dysfunction as estimated by left ventricular end-diastolic pressure and ejection fraction, and elevated pulmonary vascular resistance. Prolonged operative time was also significant. The only variable that did not seem to influence mortality was the pathology type of mitral valve involvement. Analysis of our data confirms the high risk of coronary artery by pass combined with valve replacement for mitral regurgitation reported by others, and it appears advisable at present to exercise caution in recommending combined coronary artery by pass and mitral valve replacement in patients with extensive coronary artery disease and advanced left ventricular dysfunction. Pre-and postoperative utilization of afterload reduction, with the use of circulatory assist devices, may prove effective in some patients, and deserves special evaluation.
More Related Videos
13:10Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery (ALCAPA)
Published on: April 24, 2017
08:31A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Related Concept Videos
Mitral Stenosis III: Medical Management
Mitral Stenosis I: Introduction
Mitral Regurgitation I: Introduction
Mitral Valve Prolapse II: Assessment and Management
Mitral Regurgitation III: Medical Management
Mitral Valve Prolapse I: Introduction